sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
25 Nov 2009
5.73USD
$5.73
25 Nov 2009
-2.39%
$5.87
$5.88
16,753
$5.96
$5.69
$12.29
$1.72
-1.05
87,164
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Collard, Craig |
Chairman of the Board, President, Chief Executive Officer |
925,359 |
| Price, David |
Chief Financial Officer, EVP - Finance, Principal Accounting Officer, Treasurer, Assistant Secretary |
-- |
| Powell, Andrew |
Executive Vice President, General Counsel, Secretary |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$147.42 |
| Shares Outstanding (Mil.) |
25.11 |
| Float (Mil.) |
1.80 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
0.00 |
| |
| Financial Strength |
| Quick Ratio |
0.77 |
| Current Ratio |
1.53 |
| LT Debt/Equity |
1.48 |
| Total Debt/Equity |
1.48 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
6.44 |
| Price/Sales(TTM) |
1.48 |
| Price/Book(TTM) |
0.91 |
| Price/Cash Flow(TTM) |
10.93 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$1.10 |
| Sales(TTM) |
$7.45 |
| Book Value(MRQ) |
$6.45 |
| Cash Flow(TTM) |
$1.01 |
| Cash(MRQ) |
$0.44 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
13.02 |
| Return on Assets(TTM) |
9.08 |
| Return on Investment(TTM) |
11.86 |
| |
|
| Margins |
| Gross Margin(TTM) % |
84.09 |
| Operating Margin(TTM) % |
12.32 |
| Profit Margin(TTM) % |
10.42 |
|
| |
|